[1]郭剑 李正卿.参麦注射液联合西医治疗急性下壁心肌梗死 ３０ 例[J].现代中医药,2019,(01):045-47,50.[doi:10.13424/j.cnki.mtcm.2019.01.016]
　Guo Jian Li Zhengqing.30 Cases of Acute Inferior Myocardial Infarction Treated by Shenmai Injection and Western Medicine[J].Modern Traditional Chinese Medicine,2019,(01):045-47,50.[doi:10.13424/j.cnki.mtcm.2019.01.016]
点击复制

参麦注射液联合西医治疗急性下壁心肌梗死 ３０ 例()
分享到：

《现代中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2019年01期
页码:
045-47,50
栏目:
临床研究
出版日期:
2019-01-10

文章信息/Info

Title:
30 Cases of Acute Inferior Myocardial Infarction Treated by Shenmai Injection and Western Medicine
文章编号:
1672-0571(2019)01-0045-04
作者:
郭剑 李正卿
神木市医院，陕西 神木 719300
Author(s):
Guo Jian 1 Li Zhengqing 2
Shenmu Hospital, Shenmu China, 719300
关键词:
急性心肌梗死; 参麦注射液; 脑利钠肽前体
Keywords:
acute myocardial infarction;  Shenmai Injection brain natriuretic peptide precursor
分类号:
R256.2
DOI:
10.13424/j.cnki.mtcm.2019.01.016
文献标志码:
A
摘要:
目的探讨参麦注射液在急性下壁心肌梗死中的治疗作用?方法选取我院急性下壁心肌梗死患者59例,随机分为治疗组(n=30)与对照组(n=29),对照组患者入院后立即给予急诊介入治疗,术后给予常规双联抗血小板?抗凝?调脂药物治疗,治疗组在对照的基础上加用参麦注射液静脉滴注,观察两组患者血压?心率?心功能?住院时间?脑利钠肽?高敏C反应蛋白水平变化?结果住院期间,治疗组患者有效率(93.33%)明显高于对照组(72.41%)两者比较有统计学差异(P<0.05);治疗组患者心力衰竭的发生率(6.67%)明显低于对症组
Abstract:
To investigate the curative effect of Shenmai Injection on acute inferior myocardial infarction. Method: Fifty - nine patients with acute inferior myocardial infarction in Shenmu Hospital were randomly divided into treatment group ( n = 30) and control group ( n = 29) . The patients in the control group were given emergency interventional therapy immediately after admission, and routine antiplatelet, anticoagulant and lipid - lowering drugs. The patients in the treatment group were given intravenous drip of Shenmai Injection on the basis of the control group. Blood pressure, heart rate, cardiac function, hospitalization time, brain natriuretic peptide and changes of high - sensitivity C – reactive protein levels were observed in the two groups. Result: During hospitalization, the effective rate of patients in the treatment group ( 93. 33%) was significantly higher than that in the control group ( 72.41%) , with statistical significance ( P < 0. 05) ; the incidence of heart failure in the treatment group ( 6. 67%) was significantly lower than that in the symptomatic group ( 17. 24%) , with statistical significance ( P <0. 05) ; the length of stay in the treatment group was significantly lower than that in the symptomatic group ( P <0. 05) ; The levels of - proBNP and hs - CPR in the control group were significantly higher than those in the control group, the difference is statistically significant ( P < 0. 05) .There were no adverse reactions in both groups. Conclusion: On the basis of routine drug treatment,Shenmai Injection can significantly improve the therapeutic effect of acute inferior myocardial infarction.

参考文献/References:

[1]邵占东,孙学枝,梁建成. 急性下壁心肌梗死临床并发症及特点分析 [ J]. 宁夏医学杂志,2016,38 (8):715- 716.
[2]杨晓云. 急性下壁心肌梗死的房室传导阻滞及其罪犯血管[J]. 实用心电学杂志,2016,25(4):275 - 277.
[3]曹庆艳,宗文仓,王桂平,等. 快速扩容对急性下壁心肌梗死血管再通后所致低血压疗效观察[ J]. 中国医药导刊, 2017,19(5):438 - 439.
[4]王晓明,陈念,石红玲. 冠状动脉解剖?供血特点与常见冠状动脉病变及其心电图特征[ J]. 心电图杂志( 电子版),2014,3(3):182 - 186.
[5]贺海军. 参脉注射液治疗病毒性心肌炎的临床效果[J]. 世界最新医学信息文摘,2016,16(23):148 + 150.
[6]中华医学会心血管病学分会?中华心血管病杂志编辑委员会. 急性 ST 段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病杂志. 2015, 43(5): 0253 - 3758.
[7]Kim AL, Kwon JC, Park I, et al. Reference equations forthe six - minute walk distance in healthy Korean adults,aged 22 - 59 years[J]. Tuberc Respir Dis, 2014, 76(6):269 - 275.
[8] Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker,etal. 2016 ESCguidelines for the diagnosis and treatment ofacute and chronic heart failure [ J]. European Journal ofHeart Failure,2016,18(8),891 - 975.
[9]刘香君. 右冠与左回旋支引起急性下壁心肌梗死临床观察[D]. 天津:天津医科大学,2016
[10]王振东,李宝红. 参麦注射液联合美托洛尔治疗慢性心力衰竭 32 例[J]. 现代中医药,2009,29(6):11 - 12.
[11]卢强,李联社. 参麦注射液合用咪达普利治疗扩张型心肌 病 疗 效 观 察 [ J]. 现 代 中 医 药,2010,30 (1):11- 12.
[12]张义轩, 张挚, 杨晴,等. 体外循环下经主动脉根部注射参麦注射液对二尖瓣置换术患者心肌损伤的影响[J]. 中华实验外科杂志,2014,31(7):1594 - 1596
[13]刘焯华. 参麦注射液联合尿激酶治疗急性下壁心肌梗死的疗效及对心功能的影响[J]. 医药论坛杂志,2017,38(5):160 - 162.
[14]杜军,郭慧敏,黄路非,等. 基于大数据的某院例均费用与住院天数关系研究[J]. 中国病案,2017,18(2):51- 54.

相似文献/References:

[1]郭 娟.中医活血化瘀法对急性心肌梗死患者的疗效观察[J].现代中医药,2018,(02):019.[doi:10．13424/j．cnki．mtcm．2018．02．008]
[2]闫明霞.养心通痹汤联合常规溶栓治疗急性心肌梗死临床研究[J].现代中医药,2019,(03):038.[doi:10.13424/j.cnki.mtcm.2019.03.013]
　Yan Mingxia.Effect of Yangxin Tongbi Decoction Combined with Routine Thrombolytic Therapy on Patients with Acute Myocardial Infarction[J].Modern Traditional Chinese Medicine,2019,(01):038.[doi:10.13424/j.cnki.mtcm.2019.03.013]

备注/Memo

备注/Memo:
收稿日期：２０１８－０１－２０ 编辑：杨芳艳
更新日期/Last Update: 2019-01-15